Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TELA Bio (TELA) Equity Ratio (2018 - 2025)

TELA Bio has reported Equity Ratio over the past 8 years, most recently at 0.08 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.08 for Q4 2025, down 76.41% from a year ago — trailing twelve months through Dec 2025 was 0.08 (down 76.41% YoY), and the annual figure for FY2025 was 0.08, down 76.41%.
  • Equity Ratio for Q4 2025 was 0.08 at TELA Bio, up from 0.03 in the prior quarter.
  • Over the last five years, Equity Ratio for TELA hit a ceiling of 0.53 in Q1 2021 and a floor of 0.12 in Q3 2024.
  • Median Equity Ratio over the past 5 years was 0.22 (2022), compared with a mean of 0.22.
  • Biggest five-year swings in Equity Ratio: soared 1510.97% in 2023 and later crashed 133.81% in 2024.
  • TELA Bio's Equity Ratio stood at 0.32 in 2021, then crashed by 34.39% to 0.21 in 2022, then rose by 14.75% to 0.24 in 2023, then skyrocketed by 35.89% to 0.33 in 2024, then tumbled by 76.41% to 0.08 in 2025.
  • The last three reported values for Equity Ratio were 0.08 (Q4 2025), 0.03 (Q3 2025), and 0.14 (Q2 2025) per Business Quant data.